RC TRITEC is an established company offering custom synthesis of tritium-labeled compounds, a range of tritiated catalog products, storage service and disposal of radiochemicals. We have over 60 years of experience in the safe handling of tritium gas using in-house developed high-vacuum equipment.
Products, services, technology
We produce high-quality tritiated molecules using state-of-the-art technologies. Our capabilities span precursor-dependent strategies including dehalogenation, Olefin hydrogenation, Carbonyl reduction and methylation as well as advanced direct hydrogen-isotope exchange employing transition metals.
Cooperation possibilities
Our tritium-labeled products are used in the pharmaceutical, agrochemical, and cosmetic industries. As a small Swiss company, we place great value to offering cost-effective, fast, and high-quality solutions for our international partners in the field of tritium labeling and tritium handling.
- https://www.rctritec.com/en
- +41 71 335 73 73
- Send an email
- Julian Anthony Thoma
Some insights
RC TRITEC enables safer, faster, and more efficient development of life-changing medicines through our expertise in tritium-labeled molecules. By strengthening the foundations of drug discovery, our company plays a vital role in advancing modern medicine and improving health outcomes worldwide.
We operate at the intersection of scientific excellence, innovation, and real-world impact. Our work directly supports the development of new medicines by providing highly specialized tritium-labeled molecules that are essential for early-stage pharmaceutical research.
Organizations and individuals that combine deep scientific expertise with reliability, innovation, and a strong commitment to patient impact.
RC TRITEC demonstrates strong mastery in radio-chemistry with the team’s ability to design tailored labeling strategies, adapt methods and overcome challenging molecular structures as a key competitive advantage. We stand for discipline and precision and commit to safety, integrity and compliance.
“They help make new medicines possible. They work with very small, special markers that let scientists follow how a drug behaves in the body, so researchers can decide early on which medicines are safe and effective.”
The Swiss biotech ecosystem could help RC TRITEC to strengthen collaboration and visibility within the market. We strive to expand our reaction portfolio, products and services within the field of custom-synthesis as well as for our catalog products to attract new customers.
To further strengthen RC TRITEC impact and growth in the market, meaningful engagement with established pharmaceutical and biotech companies as well as start-ups and academic research groups would especially be valuable. Greater visibility within Switzerland but also in other countries is desired.
